Gene-Disorder Association · Article
Gene
TP53 Tumor Protein P53
×
First reported
1990
Supporting publications
49
Manually curated Approved treatment annotated
Association Review
In brief The association between TP53 (Tumor Protein P53) and Sarcoma is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.
Sources
2
Clinical variants
5
Symptoms
0
Compounds
7
Trials
180 of 8,273 via TP53 compounds
Publications
49
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 2 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
ClinVar and variant evidence
Genetic basis 5 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
06
Interventions
Therapeutics 7 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials 8,273 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
49 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources 15 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access